[HTML][HTML] Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation

G Wang, G Li, F Hu, M Zang, J Pu - BMC Cardiovascular Disorders, 2023 - Springer
Background Left atrial (LA) appendage flow velocity (LAAFV) is a classic but invasive
predictor of thromboembolic events in patients with atrial fibrillation (AF). We aimed to …

Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation

G Wang, G Li, F Hu, M Zang… - BMC Cardiovascular …, 2023 - search.proquest.com
Background Left atrial (LA) appendage flow velocity (LAAFV) is a classic but invasive
predictor of thromboembolic events in patients with atrial fibrillation (AF). We aimed to …

Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation

G Wang, G Li, F Hu, M Zang, J Pu - 2022 - researchsquare.com
Background Left atrial (LA) appendage flow velocity (LAAFV) is a classic but invasive
predictor of thromboembolic events in patients with atrial fibrillation (AF). We aimed to …

Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation.

G Wang, G Li, F Hu, M Zang, J Pu - BMC Cardiovascular Disorders, 2023 - europepmc.org
Background Left atrial (LA) appendage flow velocity (LAAFV) is a classic but invasive
predictor of thromboembolic events in patients with atrial fibrillation (AF). We aimed to …

[HTML][HTML] Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation

G Wang, G Li, F Hu, M Zang… - BMC …, 2023 - bmccardiovascdisord.biomedcentral …
Left atrial (LA) appendage flow velocity (LAAFV) is a classic but invasive predictor of
thromboembolic events in patients with atrial fibrillation (AF). We aimed to explore the …

[PDF][PDF] Predicting a decrease in left atrial appendage ow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation

G Wang, G Li, F Hu, M Zang, J Pu - scholar.archive.org
Background Left atrial (LA) appendage ow velocity (LAAFV) is a classic but invasive
predictor of thromboembolic events in patients with atrial brillation (AF). We aimed to explore …

Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation

G Wang, G Li, F Hu, M Zang… - BMC cardiovascular …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Left atrial (LA) appendage flow velocity (LAAFV) is a classic but invasive
predictor of thromboembolic events in patients with atrial fibrillation (AF). We aimed to …

Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation.

G Wang, G Li, F Hu, M Zang… - BMC Cardiovascular …, 2023 - search.ebscohost.com
Background: Left atrial (LA) appendage flow velocity (LAAFV) is a classic but invasive
predictor of thromboembolic events in patients with atrial fibrillation (AF). We aimed to …

[HTML][HTML] Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation

G Wang, G Li, F Hu, M Zang, J Pu - BMC Cardiovascular Disorders, 2023 - ncbi.nlm.nih.gov
Background Left atrial (LA) appendage flow velocity (LAAFV) is a classic but invasive
predictor of thromboembolic events in patients with atrial fibrillation (AF). We aimed to …

Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation

G Wang, G Li, F Hu, M Zang, J Pu - 2022 - europepmc.org
Background: Left atrial (LA) appendage flow velocity (LAAFV) is a classic but invasive
predictor of thromboembolic events in patients with atrial fibrillation (AF). We aimed to …